SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 2.36 |
| Enterprise Value ($M) | 6.22 |
| Book Value ($M) | 0.23 |
| Book Value / Share | 0.08 |
| Price / Book | 10.29 |
| NCAV ($M) | -5.08 |
| NCAV / Share | -1.68 |
| Price / NCAV | -0.46 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -1.12 |
| Return on Assets (ROA) | -0.52 |
| Return on Equity (ROE) | -4.44 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 0.49 |
| Current Ratio | 0.86 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 5.91 |
| Assets | 11.22 |
| Liabilities | 10.99 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 5.61 |
| Operating Income | -7.36 |
| Net Income | -6.29 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -6.58 |
| Cash from Investing | 3.82 |
| Cash from Financing | 3.76 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G | Armistice Capital, Llc | 9.99 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 257 | 4,186 | 6.14 | |
| 621 | 4,570 | 13.59 | |
| 98 | 497 | 19.72 | |
| 30 | 197 | 15.23 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| APTO – Aptose Biosciences Inc. | APVO – Aptevo Therapeutics Inc. |
| ARTL – Artelo Biosciences, Inc. | ASRT – Assertio Holdings, Inc. |
| ATNF – 180 Life Sciences Corp. |
Financial data and stock pages provided by
Fintel.io